高级检索
当前位置: 首页 > 详情页

Identify the radiotherapy-induced abnormal changes in the patients with nasopharyngeal carcinoma

文献详情

资源类型:
WOS体系:

收录情况: ◇ ESCI

机构: [1]Bio-information College, Chong Qing University of Posts and Telecommunications, Chong Qing, China [2]Department of Radiotherapy, Sichuan Cancer Hospital & Institute, Chengdu, China
出处:
ISSN:

关键词: nasopharyngeal carcinoma (NPC) radiotherapy (RT) injury classification structural MRI (sMRI)

摘要:
Radiotherapy (RT) is the standard treatment for nasopharyngeal carcinoma, which often causes inevitable brain injury in the process of treatment. The majority of patients has no abnormal signal or density change of the conventional magnetic resonance imaging (MRI) and computed tomography (CT) examination in the long-term follow-up after radiation therapy. However, when there is a visible CT and conventional MR imaging changes, the damage often has been severe and lack of effective treatments, seriously influencing the prognosis of patients. Therefore, the present study aimed to investigate the abnormal changes in nasopharyngeal carcinoma (NPC) patients after RT. In the present study, we exploited the machine learning framework which contained two parts: feature extraction and classification to automatically detect the brain injury. Our results showed that the method could effectively identify the abnormal regions reduced by radiotherapy. The highest classification accuracy was 82.5 % in the abnormal brain regions. The parahippocampal gyrus was the highest accuracy region, which suggested that the parahippocampal gyrus could be most sensitive to radiotherapy and involved in the pathogenesis of radiotherapy-induced brain injury in NPC patients.

基金:
语种:
WOS:
JCR分区:
出版当年[2017]版:
最新[2023]版:
Q2 CHEMISTRY, MEDICINAL Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2016版]

第一作者:
第一作者机构: [1]Bio-information College, Chong Qing University of Posts and Telecommunications, Chong Qing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Identify the radiotherapy-induced abnormal changes in the patients with nasopharyngeal carcinoma [2]A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT). [3]Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy [4]Hypofractionated Radiotherapy with Prolonged InterFraction Interval (Hypo-Slow RT) to Facilitate Immune Priming of Tumor [5]10-Year Outcome on the Efficacy and Late Toxicities Attributed to the Addition of Concurrent-Adjuvant Chemotherapy for Stage IIII-VB Nasopharyngeal Carcinoma (Combined Analyses of the NPC-9901 and NPC-9902 Trials) [6]Assessment of self-reported financial toxicity among patients with nasopharyngeal carcinoma undergoing radiotherapy: A cross-sectional study in western China [7]An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma (NPC): Preliminary report [8]Zinc Transporter 4 (ZIP4): A Predictive Biomarker for Decreasing Radiosensitivity and Promoting Tumor Migration and Metastasis Through TGF-beta-Dependent Manner in Nasopharyngeal Carcinoma (NPC) [9]Long-term result of a multicenter clinical study of cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC). [10]Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial

资源点击量:43378 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号